EyeGene De Facto Controlling Shareholder U Gu Increases Stake to 2.14% via Open Market Purchases

U Gu, the de facto controlling shareholder and officer of EyeGene, increased his shareholding from 790,810 shares to 926,054 shares through open market purchases from June 16 to June 19, 2026.
The increase of 135,244 shares represents approximately 0.31% of total outstanding shares, raising his ownership stake from 1.83% to 2.14%.
This insider buying signals confidence in the company's prospects but has no direct impact on capital structure or dilution.
[AI Summary]The insider's open market purchases indicate positive sentiment, but due to the small relative size, the overall impact on shareholder value is neutral.